Evidence map›Paper›PMID 32253837›Full record

ReviewJournal of Zhejiang University. Science. B

Effects of sulforaphane on brain mitochondria: mechanistic view and future directions.

Fernanda Rafaela Jardim, Fhelipe Jolner Souza de Almeida, Matheus Dargesso Luckachaki, Marcos Roberto de Oliveira

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of Zhejiang University. Science. B. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Journal of Zhejiang University. Science. B · 2023
    Article
  6. Article
  7. Article
  8. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Fernanda Rafaela JardimForensic Institute, Forensic Toxicology Division, Postmortem Toxicology Sector, CEP 90160-093, Porto Alegre, RS, Brazil.
Fhelipe Jolner Souza de AlmeidaPostgraduate Program in Health Sciences (PPGCS), Federal University of Mato Grosso (UFMT), CEP 78060-900, Cuiaba, MT, Brazil.
Matheus Dargesso LuckachakiDepartment of Chemistry, Federal University of Mato Grosso (UFMT), CEP 78060-900, Cuiaba, MT, Brazil.
Marcos Roberto de OliveiraPostgraduate Program in Chemistry (PPGQ), Federal University of Mato Grosso (UFMT), CEP 78060-900, Cuiaba, MT, Brazil.
Universidade Federal de Mato Grosso · BRCentral Forensic Science Laboratory · INUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The organosulfur compound sulforaphane (SFN; C

Indexed as

AnimalsAntioxidantsApoptosisBrainCarbon Monoxide PoisoningCytoprotectionHumansIsothiocyanatesMembrane Potential, MitochondrialMitochondriaSulfoxidesAntioxidantsIsothiocyanatessulforaphaneSulfoxidesSulforaphane; Brain; Mitochondria; Antioxidant; Nuclear factor erythroid 2-related factor 2 (Nrf2)

Identifiers

PMID32253837
PMCPMC7183447
OpenAlexW3015110163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.